- Home
- NMIH vs VKTX Comparison
NMIH vs VKTX Comparison
Compare NMIH & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMIH | VKTX |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NMIH | VKTX |
|---|---|---|
| Price | $42.11 | $25.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 21 |
| Target Price | $48.88 | ★ $95.05 |
| AVG Volume (30 Days) | 767.8K | ★ 4.7M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.06 | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $706,440,000.00 | N/A |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | $5.40 | N/A |
| P/E Ratio | $15.98 | ★ N/A |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $34.84 | $23.82 |
| 52 Week High | $46.74 | $43.15 |
Technical Indicators
Market Signals| Indicator | NMIH | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 39.09 |
| Support Level | $40.97 | N/A |
| Resistance Level | $43.36 | $35.23 |
| Average True Range (ATR) | 1.01 | 1.31 |
| MACD | 0.40 | -0.05 |
| Stochastic Oscillator | 72.19 | 24.41 |
Price Performance
Historical ComparisonAbout NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.